Free Trial
→ One executive order. The biggest wealth transfer of your lifetime. (From Reagan Gold Group) (Ad)tc pixel Free THG Stock Alerts

The Hanover Insurance Group (THG) Financials

The Hanover Insurance Group logo
$186.22 -0.15 (-0.08%)
Closing price 05/7/2026 03:59 PM Eastern
Extended Trading
$186.30 +0.08 (+0.04%)
As of 04:07 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for The Hanover Insurance Group

Annual Income Statements for The Hanover Insurance Group

This table shows The Hanover Insurance Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 332 155 186 391 425 359 423 116 35 426 663
Consolidated Net Income / (Loss)		 332 155 186 391 425 359 423 116 35 426 663
Net Income / (Loss) Continuing Operations		 331 67 216 239 429 362 420 117 34 425 661
Total Pre-Tax Income 		439 66 293 283 522 445 521 144 41 538 844
Total Revenue		 4,988 4,173 4,228 4,464 4,747 4,801 5,075 5,500 5,973 6,195 6,536
Net Interest Income / (Expense)		 -61 -51 -45 -45 -38 -37 -34 -34 -34 -34 -43
Total Interest Income		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense		 61 51 45 45 38 37 34 34 34 34 43
Long-Term Debt Interest Expense		 61 51 45 45 38 37 34 34 34 34 43
Total Non-Interest Income		 5,048 4,225 4,274 4,510 4,784 4,838 5,109 5,534 6,007 6,229 6,579
Other Service Charges		 31 23 23 23 26 27 24 27 31 28 25
Net Realized & Unrealized Capital Gains on Investments		 313 413 271 237 286 283 315 255 313 288 393
Premiums Earned		 4,705 3,790 3,980 4,254 4,475 4,527 4,770 5,252 5,663 5,913 6,161
Total Non-Interest Expense		 4,548 4,107 3,935 4,139 4,331 4,353 4,672 5,292 5,926 5,675 5,713
Property & Liability Insurance Claims		 2,884 2,546 2,580 2,725 2,866 2,845 3,134 3,623 4,135 3,757 3,729
Other Operating Expenses		 631 730 510 522 539 557 555 574 608 690 696
Amortization Expense		 1,033 804 841 892 927 951 983 1,093 1,176 1,222 1,285
Impairment Charge		 - 27 5.60 - - - - 1.90 7.70 5.80 3.10
Nonoperating Income / (Expense), net		 - - - -43 107 - 119 -63 -5.60 14 19
Income Tax Expense		 109 -1.00 77 44 93 83 101 27 7.60 113 183
Net Income / (Loss) Discontinued Operations		 0.70 -1.00 -30 152 -3.90 -3.30 2.80 -0.80 1.80 0.70 1.80
Basic Earnings per Share		 $7.55 $3.63 $4.38 $9.21 $10.62 $9.52 $11.78 $3.26 $0.99 $11.85 $18.50
Weighted Average Basic Shares Outstanding		 43.90M 42.80M 42.50M 42.40M 40M 37.70M 35.90M 35.60M 35.70M 35.90M 35.80M
Diluted Earnings per Share		 $7.40 $3.59 $4.33 $9.09 $10.46 $9.42 $11.60 $3.21 $0.98 $11.70 $18.16
Weighted Average Diluted Shares Outstanding		 44.80M 43.20M 43M 43M 40.60M 38.10M 36.40M 36.10M 36.10M 36.40M 36.50M
Weighted Average Basic & Diluted Shares Outstanding		 43.90M 42.70M 42.50M 40.57M 38.45M 36.39M 35.48M 35.60M 35.82M 35.93M 35.15M

Quarterly Income Statements for The Hanover Insurance Group

This table shows The Hanover Insurance Group's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 8.60 108 116 41 102 168 128 157 179 199 187
Consolidated Net Income / (Loss)		 8.60 108 116 41 102 168 128 157 179 199 187
Net Income / (Loss) Continuing Operations		 8.20 107 116 40 102 167 128 157 179 197 187
Total Pre-Tax Income 		-0.90 150 145 51 130 212 160 199 227 258 237
Total Revenue		 1,513 1,519 1,536 1,531 1,546 1,583 1,594 1,643 1,642 1,656 1,688
Net Interest Income / (Expense)		 -8.50 -8.50 -8.50 -8.60 -8.50 -8.50 -8.50 -8.60 -12 -15 -11
Total Interest Income		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Interest Expense		 8.50 8.50 8.50 8.60 8.50 8.50 8.50 8.60 12 15 11
Long-Term Debt Interest Expense		 8.50 8.50 8.50 8.60 8.50 8.50 8.50 8.60 12 15 11
Total Non-Interest Income		 1,522 1,527 1,545 1,539 1,554 1,591 1,602 1,652 1,654 1,671 1,699
Other Service Charges		 7.40 7.60 7.30 7.60 6.70 6.40 6.40 6.10 6.30 6.10 6.20
Net Realized & Unrealized Capital Gains on Investments		 83 64 88 58 68 73 87 101 97 108 122
Premiums Earned		 1,431 1,440 1,449 1,473 1,479 1,512 1,509 1,545 1,551 1,557 1,571
Total Non-Interest Expense		 1,509 1,376 1,397 1,480 1,428 1,370 1,435 1,450 1,426 1,403 1,457
Property & Liability Insurance Claims		 1,062 916 935 1,008 954 861 955 957 927 890 958
Other Operating Expenses		 151 156 163 166 165 196 165 171 174 185 164
Amortization Expense		 297 298 299 304 308 311 314 319 325 327 333
Impairment Charge		 0.00 - - 3.50 0.60 - 0.00 2.50 0.10 - 2.00
Nonoperating Income / (Expense), net		 -5.20 7.80 6.50 1.10 12 -5.10 1.00 5.00 11 1.40 4.60
Income Tax Expense		 -9.10 43 30 11 28 44 32 42 49 61 50
Basic Earnings per Share		 $0.24 $3.03 $3.22 $1.13 $2.84 $4.66 $3.56 $4.37 $4.99 $5.58 $5.30
Weighted Average Basic Shares Outstanding		 35.80M 35.70M 35.80M 36M 36M 35.90M 36M 35.90M 35.80M 35.80M 35.20M
Diluted Earnings per Share		 $0.24 $3.02 $3.18 $1.12 $2.80 $4.60 $3.50 $4.30 $4.90 $5.46 $5.20
Weighted Average Diluted Shares Outstanding		 36.10M 36.10M 36.30M 36.30M 36.50M 36.40M 36.60M 36.50M 36.40M 36.50M 35.90M
Weighted Average Basic & Diluted Shares Outstanding		 35.76M 35.82M 35.94M 35.98M 36.03M 35.93M 35.92M 35.77M 35.58M 35.15M 34.99M

Annual Cash Flow Statements for The Hanover Insurance Group

This table details how cash moves in and out of The Hanover Insurance Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -35 -56 94 648 -808 -95 110 74 11 120 687
Net Cash From Operating Activities		 445 743 705 551 603 708 824 722 362 806 1,178
Net Cash From Continuing Operating Activities		 445 743 705 188 603 708 824 722 362 806 1,178
Net Income / (Loss) Continuing Operations		 332 155 186 0.00 425 359 423 116 35 426 663
Consolidated Net Income / (Loss)		 332 155 186 - 425 359 423 116 35 426 663
Depreciation Expense		 30 31 30 -25 22 18 17 13 6.30 1.50 -4.60
Amortization Expense		 13 9.90 14 9.70 11 6.00 3.40 5.50 7.90 6.80 6.70
Non-Cash Adjustments to Reconcile Net Income		 -21 92 -11 -224 -91 21 -100 135 63 107 82
Changes in Operating Assets and Liabilities, net		 91 456 486 790 235 304 481 453 249 265 432
Net Cash From Investing Activities		 -172 -495 -506 271 -312 -609 -460 -508 -229 -541 -666
Net Cash From Continuing Investing Activities		 -172 -495 -506 271 -312 -609 -460 -508 -229 -541 -666
Purchase of Property, Leasehold Improvements and Equipment		 -20 -16 -19 -13 -13 -15 -8.00 -18 -12 -10 -7.70
Purchase of Investment Securities		 -2,222 -2,372 -1,878 -1,604 -1,921 -2,084 -2,303 -2,085 -1,131 -3,313 -3,386
Sale and/or Maturity of Investments		 2,026 1,892 1,390 1,253 1,587 1,490 1,851 1,595 914 2,782 2,728
Net Cash From Financing Activities		 -301 -301 -112 -171 -1,099 -194 -253 -141 -122 -146 175
Net Cash From Continuing Financing Activities		 -301 -301 -112 -171 -1,099 -194 -253 -141 -122 -146 175
Issuance of Debt		 - 371 - 0.00 0.00 296 - - 0.00 0.00 495
Repayment of Debt		 -114 -475 - -12 -151 -176 - - 0.00 0.00 -62
Repurchase of Common Equity		 -127 -106 -37 -58 -564 -213 -163 -31 0.00 -27 -129
Payment of Dividends		 -74 -80 -87 -94 -386 -100 -102 -109 -117 -124 -131
Other Financing Activities, Net		 15 -10 12 -7.40 1.60 -2.20 12 -0.90 -4.90 5.30 1.80
Other Net Changes in Cash		 - - - - 3.30 0.00 0.00 0.00 0.00 -0.60 0.10
Cash Interest Paid		 61 53 48 48 37 34 33 33 33 33 33
Cash Income Taxes Paid		 57 30 51 57 114 97 74 108 -22 149 169

Quarterly Cash Flow Statements for The Hanover Insurance Group

This table details how cash moves in and out of The Hanover Insurance Group's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 127 22 -52 77 86 8.60 -121 -71 674 205 -880
Net Cash From Operating Activities		 225 93 59 140 395 214 39 207 554 378 119
Net Cash From Continuing Operating Activities		 225 93 59 140 395 214 39 207 554 378 119
Net Income / (Loss) Continuing Operations		 8.60 108 116 41 102 168 128 157 179 199 187
Consolidated Net Income / (Loss)		 8.60 108 116 41 102 168 128 157 179 199 187
Depreciation Expense		 1.50 0.80 0.80 0.80 0.50 -0.60 -1.10 -1.00 -1.20 -1.30 -1.80
Amortization Expense		 1.90 2.00 1.70 1.70 1.70 1.70 1.60 1.70 1.70 1.70 1.70
Non-Cash Adjustments to Reconcile Net Income		 15 7.90 1.20 43 21 42 25 14 19 24 9.10
Changes in Operating Assets and Liabilities, net		 198 -26 -61 54 269 2.50 -115 35 356 155 -77
Net Cash From Investing Activities		 -68 -42 -75 -34 -282 -150 -112 -222 -308 -24 -494
Net Cash From Continuing Investing Activities		 -68 -42 -75 -34 -282 -150 -112 -222 -308 -24 -494
Purchase of Property, Leasehold Improvements and Equipment		 -2.90 -2.20 -2.60 -2.20 -2.40 -3.00 -1.80 -1.70 -3.00 -1.20 -3.50
Purchase of Investment Securities		 -313 -329 -304 -935 -957 -1,118 -828 -1,038 -1,007 -515 -1,160
Sale and/or Maturity of Investments		 248 289 232 903 677 970 717 817 701 492 670
Net Cash From Financing Activities		 -29 -29 -35 -29 -27 -55 -48 -55 428 -150 -505
Net Cash From Continuing Financing Activities		 -29 -29 -35 -29 -27 -55 -48 -55 428 -150 -505
Repayment of Debt		 - - - - - - 0.00 - - - -375
Repurchase of Common Equity		 - - 0.00 - - -27 -11 -28 -36 -55 -87
Payment of Dividends		 -29 -30 -31 -31 -31 -32 -32 -32 -32 -34 -34
Other Financing Activities, Net		 -0.40 1.30 -4.90 2.00 3.90 4.30 -4.10 4.60 0.80 0.50 -9.20
Other Net Changes in Cash		 - - 0.00 - - -0.20 0.50 -0.20 -2.20 2.00 0.40

Annual Balance Sheets for The Hanover Insurance Group

This table presents The Hanover Insurance Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 13,781 14,220 15,470 12,400 12,491 13,444 14,254 13,995 14,613 15,275 16,946
Cash and Due from Banks		 339 283 298 1,021 216 121 231 305 316 436 1,123
Trading Account Securities		 7,560 7,916 6,326 6,626 7,263 8,053 8,385 7,724 8,116 8,700 9,721
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income		 63 62 48 53 53 51 50 55 58 70 80
Unearned Premiums Asset		 1,392 1,438 1,096 1,177 1,260 1,339 1,470 1,601 1,706 1,801 1,861
Deferred Acquisition Cost		 509 518 430 451 467 478 552 605 621 663 703
Goodwill		 186 185 179 179 179 179 179 179 179 179 179
Other Assets		 3,733 3,820 7,094 2,894 3,052 3,223 3,388 3,527 3,617 3,427 3,279
Total Liabilities & Shareholders' Equity		 13,781 14,220 15,470 12,400 12,491 13,444 14,254 13,995 14,613 15,275 16,946
Total Liabilities		 10,937 11,363 12,472 9,445 9,574 10,242 11,109 11,661 12,147 12,433 13,374
Short-Term Debt		 - - - - - - - - 0.00 62 375
Other Short-Term Payables		 725 728 - 910 628 688 908 732 776 758 807
Long-Term Debt		 803 786 787 778 653 781 782 782 783 722 843
Claims and Claim Expense		 6,574 6,949 5,059 5,304 5,654 6,024 6,448 7,013 7,308 7,461 7,755
Unearned Premiums Liability		 2,541 2,561 2,132 2,278 2,417 2,483 2,735 2,954 3,103 3,283 3,440
Other Long-Term Liabilities		 294 338 4,495 175 222 267 238 181 177 146 154
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 2,844 2,858 2,998 2,955 2,916 3,202 3,145 2,334 2,466 2,842 3,572
Total Preferred & Common Equity		 2,844 2,858 2,998 2,955 2,916 3,202 3,145 2,334 2,466 2,842 3,572
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 2,844 2,858 2,998 2,955 2,916 3,202 3,145 2,334 2,466 2,842 3,572
Common Stock		 1,834 1,847 1,858 1,872 1,838 1,858 1,888 1,914 1,940 1,974 2,014
Retained Earnings		 1,804 1,876 1,975 2,182 2,411 2,668 2,983 2,993 2,909 3,210 3,742
Treasury Stock		 -847 -928 -943 -984 -1,485 -1,696 -1,848 -1,871 -1,866 -1,886 -2,013
Accumulated Other Comprehensive Income / (Loss)		 54 63 108 -117 153 373 122 -702 -517 -456 -171

Quarterly Balance Sheets for The Hanover Insurance Group

This table presents The Hanover Insurance Group's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 13,746 14,092 14,187 14,315 14,594 14,872 15,367 15,470 15,732 16,774 16,528
Cash and Due from Banks		 165 182 168 295 265 338 427 315 244 916 244
Trading Account Securities		 7,600 7,913 7,831 7,742 8,153 8,198 8,770 8,969 9,251 9,682 10,164
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income		 50 54 56 56 58 62 64 66 76 73 76
Unearned Premiums Asset		 1,624 1,600 1,674 1,771 1,740 1,814 1,882 1,809 1,895 1,932 1,856
Deferred Acquisition Cost		 600 598 606 631 619 635 663 657 675 708 691
Goodwill		 179 179 179 179 179 179 179 179 179 179 179
Other Assets		 3,528 3,566 3,674 3,641 3,581 3,648 3,382 3,475 3,414 3,285 3,318
Total Liabilities & Shareholders' Equity		 13,746 14,092 14,187 14,315 14,594 14,872 15,367 15,470 15,732 16,774 16,528
Total Liabilities		 11,450 11,703 11,949 12,199 12,071 12,320 12,489 12,426 12,516 13,348 12,957
Short-Term Debt		 - - - - - - - 62 437 437 50
Other Short-Term Payables		 723 619 652 728 679 735 775 619 602 703 651
Long-Term Debt		 782 783 783 783 783 784 784 723 348 843 794
Claims and Claim Expense		 6,774 7,143 7,313 7,330 7,331 7,463 7,427 7,609 7,636 7,707 7,911
Unearned Premiums Liability		 2,972 2,969 3,021 3,188 3,105 3,168 3,339 3,259 3,335 3,509 3,402
Other Long-Term Liabilities		 199 189 180 170 173 170 164 155 158 151 150
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 2,296 2,389 2,238 2,116 2,523 2,552 2,878 3,044 3,216 3,426 3,570
Total Preferred & Common Equity		 2,296 2,389 2,238 2,116 2,523 2,552 2,878 3,044 3,216 3,426 3,570
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 2,296 2,389 2,238 2,116 2,523 2,552 2,878 3,044 3,216 3,426 3,570
Common Stock		 1,905 1,914 1,924 1,932 1,942 1,953 1,964 1,979 1,995 2,005 2,017
Retained Earnings		 3,030 2,952 2,853 2,832 2,994 3,003 3,075 3,307 3,431 3,577 3,895
Treasury Stock		 -1,873 -1,869 -1,868 -1,868 -1,864 -1,863 -1,861 -1,897 -1,922 -1,958 -2,103
Accumulated Other Comprehensive Income / (Loss)		 -766 -608 -671 -780 -549 -541 -300 -345 -287 -198 -238

Annual Metrics And Ratios for The Hanover Insurance Group

This table displays calculated financial ratios and metrics derived from The Hanover Insurance Group's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - - -
Valuation Ratios		 - - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Efficiency Ratios		 - - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - - -
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $7.55 $3.63 $4.38 $9.21 $10.62 $9.52 $11.67 $3.26 $0.99 $11.85 $18.50
Adjusted Weighted Average Basic Shares Outstanding		 43.90M 42.80M 42.50M 42.40M 40M 37.70M 35.90M 35.60M 35.70M 35.90M 35.80M
Adjusted Diluted Earnings per Share		 $7.40 $3.59 $4.33 $9.09 $10.46 $9.42 $11.49 $3.21 $0.98 $11.70 $18.16
Adjusted Weighted Average Diluted Shares Outstanding		 44.80M 43.20M 43M 43M 40.60M 38.10M 36.40M 36.10M 36.10M 36.40M 36.50M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $10.62 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 42.82M 42.50M 42.50M 40.57M 38.45M 36.39M 35.48M 35.60M 35.82M 35.93M 35.15M
Debt Service Ratios		 - - - - - - - - - - -
Payout Ratios		 - - - - - - - - - - -

Quarterly Metrics And Ratios for The Hanover Insurance Group

This table displays calculated financial ratios and metrics derived from The Hanover Insurance Group's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 35,149,316.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 35,149,316.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 5.31
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 10.76% 0.01% 6.50% 2.13% 2.14% 4.22% 3.75% 7.37% 6.24% - 5.92%
EBITDA Growth		 -45.77% 297.81% 2,383.87% 161.42% 1,459.74% 47.31% 12.95% 269.07% 80.02% - 44.61%
EBIT Growth		 -52.22% 342.24% 1,437.50% 156.03% 2,641.86% 49.44% 14.63% 286.06% 82.95% - 45.13%
NOPAT Growth		 -91.53% 1,088.61% 1,615.56% 163.03% 2,986.04% 68.42% 15.47% 286.89% 82.62% - 43.78%
Net Income Growth		 1,620.00% 991.74% 1,062.50% 158.53% 1,087.21% 55.61% 11.00% 287.90% 75.02% - 45.71%
EPS Growth		 2,300.00% 1,015.15% 1,035.29% 157.73% 1,066.67% 52.32% 10.06% 283.93% 75.00% - 48.57%
Operating Cash Flow Growth		 -28.69% -53.30% 224.31% 432.44% 75.66% 130.31% -33.73% 48.10% 40.46% - 205.40%
Free Cash Flow Firm Growth		 -78.38% -103.87% -105.55% -201.96% -468.19% -564.36% -1,535.30% -85.75% -30.69% - -1.80%
Invested Capital Growth		 -5.81% 4.26% 4.24% 10.43% 26.29% 11.61% 15.81% 19.93% 28.53% - 15.29%
Revenue Q/Q Growth		 0.98% 0.34% 1.67% -0.36% 0.99% 2.39% 0.70% 3.11% -0.07% - 1.91%
EBITDA Q/Q Growth		 108.97% 1,785.71% -2.48% -62.78% 127.89% 78.10% -25.39% 21.87% 11.16% - -9.21%
EBIT Q/Q Growth		 104.80% 3,211.63% -2.32% -63.91% 134.86% 80.49% -25.24% 21.81% 11.30% - -9.02%
NOPAT Q/Q Growth		 104.80% 3,279.66% 8.46% -64.17% 134.96% 84.45% -25.64% 20.06% 10.91% - -6.51%
Net Income Q/Q Growth		 112.43% 1,154.65% 7.04% -64.94% 152.10% 64.45% -23.65% 22.54% 13.75% - -5.89%
EPS Q/Q Growth		 112.37% 1,158.33% 5.30% -64.78% 150.00% 64.29% -23.91% 22.86% 13.95% - -4.76%
Operating Cash Flow Q/Q Growth		 757.63% -58.75% -36.68% 137.65% 182.94% -45.91% -81.78% 431.11% 168.34% - -68.59%
Free Cash Flow Firm Q/Q Growth		 -32.76% -117.04% 21.97% -1,040.68% -142.83% 69.26% -92.06% -29.57% -70.86% - 58.44%
Invested Capital Q/Q Growth		 -4.02% 12.05% 1.76% 0.90% 9.76% -0.98% 5.59% 4.50% 17.63% - -7.84%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 0.51% 9.56% 9.22% 3.44% 7.77% 13.52% 10.01% 11.84% 13.17% - 13.67%
EBIT Margin		 0.28% 9.38% 9.06% 3.28% 7.63% 13.45% 9.98% 11.79% 13.14% - 13.68%
Profit (Net Income) Margin		 0.57% 7.11% 7.52% 2.65% 6.61% 10.61% 8.04% 9.56% 10.88% - 11.07%
Tax Burden Percent		 -955.56% 71.84% 79.49% 78.95% 78.72% 79.39% 80.08% 79.02% 78.69% - 78.79%
Interest Burden Percent		 -20.93% 105.48% 104.46% 102.19% 110.01% 99.39% 100.63% 102.58% 105.29% - 102.69%
Effective Tax Rate		 0.00% 28.56% 20.51% 21.25% 21.28% 20.90% 19.93% 21.08% 21.36% - 21.21%
Return on Invested Capital (ROIC)		 0.40% 12.57% 13.44% 4.95% 11.22% 19.51% 14.01% 16.15% 15.95% - 17.46%
ROIC Less NNEP Spread (ROIC-NNEP)		 1.11% 13.36% 14.10% 5.07% 12.39% 19.07% 14.11% 16.68% 16.83% - 17.90%
Return on Net Nonoperating Assets (RNNOA)		 0.39% 4.36% 4.49% 1.66% 3.89% 5.63% 3.97% 4.53% 5.51% - 4.41%
Return on Equity (ROE)		 0.79% 16.93% 17.93% 6.61% 15.11% 25.14% 17.99% 20.69% 21.47% - 21.86%
Cash Return on Invested Capital (CROIC)		 3.08% -2.97% 0.62% -1.63% -12.74% 1.08% -2.56% -3.28% -10.12% - 2.82%
Operating Return on Assets (OROA)		 0.12% 3.92% 3.83% 1.38% 3.15% 5.57% 4.15% 4.91% 5.28% - 5.67%
Return on Assets (ROA)		 0.24% 2.97% 3.18% 1.11% 2.73% 4.40% 3.35% 3.98% 4.38% - 4.59%
Return on Common Equity (ROCE)		 0.79% 16.93% 17.93% 6.61% 15.11% 25.14% 17.99% 20.69% 21.47% - 21.86%
Return on Equity Simple (ROE_SIMPLE)		 -4.00% 0.00% 6.45% 10.68% 12.72% 0.00% 14.41% 17.27% 18.44% - 20.20%
Net Operating Profit after Tax (NOPAT)		 3.01 102 110 40 93 171 127 153 170 - 183
NOPAT Margin		 0.20% 6.70% 7.18% 2.58% 6.01% 10.83% 7.99% 9.31% 10.33% - 10.85%
Net Nonoperating Expense Percent (NNEP)		 -0.71% -0.79% -0.66% -0.12% -1.18% 0.44% -0.10% -0.53% -0.88% - -0.45%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Operating Expenses to Revenue		 99.72% 90.62% 90.94% 96.72% 92.37% 86.55% 90.02% 88.21% 86.86% - 86.32%
Earnings before Interest and Taxes (EBIT)		 4.30 142 139 50 118 213 159 194 216 - 231
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 7.70 145 142 53 120 214 160 195 216 - 231
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.83 1.72 1.92 1.77 1.85 1.96 2.05 1.90 1.90 - 1.71
Price to Tangible Book Value (P/TBV)		 2.00 1.85 2.06 1.90 1.97 2.09 2.18 2.01 2.00 - 1.80
Price to Revenue (P/Rev)		 0.65 0.71 0.80 0.74 0.87 0.90 1.00 0.96 1.01 - 0.92
Price to Earnings (P/E)		 0.00 119.96 29.71 16.55 14.56 13.08 14.25 10.99 10.28 - 8.45
Dividend Yield		 3.00% 2.77% 2.46% 2.68% 2.30% 2.23% 2.01% 2.09% 1.98% - 2.13%
Earnings Yield		 0.00% 0.83% 3.37% 6.04% 6.87% 7.64% 7.02% 9.10% 9.73% - 11.83%
Enterprise Value to Invested Capital (EV/IC)		 1.50 1.45 1.62 1.49 1.55 1.63 1.75 1.66 1.46 - 1.52
Enterprise Value to Revenue (EV/Rev)		 0.73 0.79 0.88 0.81 0.93 0.96 1.07 1.04 1.06 - 1.01
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 77.20 25.66 14.27 12.37 11.21 12.29 9.65 8.75 - 7.47
Enterprise Value to EBIT (EV/EBIT)		 0.00 100.68 27.29 14.75 12.65 11.39 12.44 9.71 8.78 - 7.49
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 123.52 34.62 18.81 16.50 14.30 15.58 12.20 11.04 - 9.54
Enterprise Value to Operating Cash Flow (EV/OCF)		 9.31 13.00 13.31 9.61 8.29 7.34 8.54 7.78 6.77 - 5.32
Enterprise Value to Free Cash Flow (EV/FCFF)		 47.26 0.00 265.32 0.00 0.00 160.17 0.00 0.00 0.00 - 57.55
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.37 0.32 0.31 0.31 0.27 0.28 0.26 0.24 0.37 - 0.24
Long-Term Debt to Equity		 0.37 0.32 0.31 0.31 0.27 0.25 0.24 0.11 0.25 - 0.22
Financial Leverage		 0.35 0.33 0.32 0.33 0.31 0.30 0.28 0.27 0.33 - 0.25
Leverage Ratio		 6.36 5.96 5.84 6.07 5.94 5.63 5.40 5.31 5.10 - 4.84
Compound Leverage Factor		 -1.33 6.29 6.10 6.20 6.54 5.60 5.43 5.44 5.37 - 4.97
Debt to Total Capital		 27.01% 24.11% 23.70% 23.49% 21.41% 21.63% 20.48% 19.61% 27.19% - 19.12%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 1.70% 1.61% 10.92% 9.28% - 1.14%
Long-Term Debt to Total Capital		 27.01% 24.11% 23.70% 23.49% 21.41% 19.92% 18.87% 8.69% 17.91% - 17.98%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Common Equity to Total Capital		 72.99% 75.89% 76.30% 76.51% 78.59% 78.38% 79.52% 80.39% 72.81% - 80.88%
Debt to EBITDA		 -16.38 12.86 3.75 2.26 1.71 1.48 1.43 1.14 1.63 - 0.94
Net Debt to EBITDA		 -10.22 7.67 2.49 1.28 0.78 0.66 0.86 0.79 0.46 - 0.67
Long-Term Debt to EBITDA		 -16.38 12.86 3.75 2.26 1.71 1.37 1.32 0.51 1.07 - 0.89
Debt to NOPAT		 -9.04 20.58 5.06 2.98 2.28 1.89 1.82 1.44 2.06 - 1.20
Net Debt to NOPAT		 -5.64 12.27 3.35 1.69 1.04 0.84 1.09 0.99 0.59 - 0.86
Long-Term Debt to NOPAT		 -9.04 20.58 5.06 2.98 2.28 1.74 1.68 0.64 1.36 - 1.13
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 182 -31 -24 -276 -669 -206 -395 -512 -875 - -402
Operating Cash Flow to CapEx		 7,748.28% 4,213.64% 2,257.69% 6,340.91% 16,445.83% 7,116.67% 2,161.11% 12,152.94% 18,480.00% - 3,394.29%
Free Cash Flow to Firm to Interest Expense		 21.39 -3.64 -2.84 -32.05 -78.75 -24.21 -46.49 -59.54 -75.42 - -37.25
Operating Cash Flow to Interest Expense		 26.44 10.91 6.91 16.22 46.44 25.12 4.58 24.02 47.79 - 11.00
Operating Cash Flow Less CapEx to Interest Expense		 26.09 10.65 6.60 15.97 46.15 24.76 4.36 23.83 47.53 - 10.68
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.43 0.42 0.42 0.42 0.41 0.41 0.42 0.42 0.40 - 0.41
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 2,899 3,249 3,306 3,336 3,662 3,626 3,829 4,001 4,706 - 4,414
Invested Capital Turnover		 2.00 1.88 1.87 1.92 1.87 1.80 1.75 1.74 1.54 - 1.61
Increase / (Decrease) in Invested Capital		 -179 133 135 315 762 377 523 665 1,045 - 586
Enterprise Value (EV)		 4,354 4,702 5,355 4,955 5,686 5,922 6,719 6,642 6,861 - 6,693
Market Capitalization		 3,866 4,235 4,836 4,509 5,330 5,573 6,249 6,101 6,497 - 6,093
Book Value per Share		 $59.19 $68.94 $70.47 $71.01 $79.97 $78.87 $84.74 $89.55 $95.78 - $101.58
Tangible Book Value per Share		 $54.19 $63.94 $65.47 $66.03 $75.00 $73.90 $79.76 $84.57 $90.78 - $96.49
Total Capital		 2,899 3,249 3,306 3,336 3,662 3,626 3,829 4,001 4,706 - 4,414
Total Debt		 783 783 783 784 784 784 784 785 1,280 - 844
Total Long-Term Debt		 783 783 783 784 784 722 723 348 843 - 794
Net Debt		 489 467 519 446 357 349 469 541 364 - 600
Capital Expenditures (CapEx)		 2.90 2.20 2.60 2.20 2.40 3.00 1.80 1.70 3.00 - 3.50
Net Nonoperating Expense (NNE)		 -5.59 -6.17 -5.17 -0.97 -9.21 3.43 -0.80 -4.15 -9.07 - -3.62
Net Nonoperating Obligations (NNO)		 783 783 783 784 784 784 784 785 1,280 - 844
Total Depreciation and Amortization (D&A)		 3.40 2.80 2.50 2.50 2.20 1.10 0.50 0.70 0.50 - -0.10
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.24 $3.03 $3.22 $1.13 $2.84 $4.66 $3.56 $4.37 $4.99 $5.58 $5.30
Adjusted Weighted Average Basic Shares Outstanding		 35.80M 35.70M 35.80M 36M 36M 35.90M 36M 35.90M 35.80M 35.80M 35.20M
Adjusted Diluted Earnings per Share		 $0.24 $3.02 $3.18 $1.12 $2.80 $4.60 $3.50 $4.30 $4.90 $5.46 $5.20
Adjusted Weighted Average Diluted Shares Outstanding		 36.10M 36.10M 36.30M 36.30M 36.50M 36.40M 36.60M 36.50M 36.40M 36.50M 35.90M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 35.76M 35.82M 35.94M 35.98M 36.03M 35.93M 35.92M 35.77M 35.58M 35.15M 34.99M
Normalized Net Operating Profit after Tax (NOPAT)		 3.01 102 110 42 93 171 127 155 170 - 185
Normalized NOPAT Margin		 0.20% 6.70% 7.18% 2.76% 6.04% 10.83% 7.99% 9.43% 10.34% - 10.95%
Pre Tax Income Margin		 -0.06% 9.89% 9.46% 3.35% 8.39% 13.36% 10.05% 12.10% 13.83% - 14.05%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.51 16.75 16.36 5.84 13.87 25.04 18.72 22.53 18.59 - 21.38
NOPAT to Interest Expense		 0.35 11.97 12.98 4.60 10.93 20.16 14.99 17.79 14.62 - 16.96
EBIT Less CapEx to Interest Expense		 0.16 16.49 16.06 5.58 13.59 24.68 18.51 22.34 18.34 - 21.06
NOPAT Less CapEx to Interest Expense		 0.01 11.71 12.67 4.34 10.65 19.80 14.78 17.59 14.37 - 16.64
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 -136.60% 332.01% 72.97% 44.18% 33.33% 29.13% 28.72% 23.00% 20.46% - 18.26%
Augmented Payout Ratio		 -136.60% 332.01% 72.97% 44.18% 33.33% 35.40% 37.31% 34.76% 36.49% - 46.71%

Financials Breakdown Chart

Key Financial Trends

The Hanover Insurance Group (THG) shows improving profitability and steady top-line growth in the 2025 quarters, supported by stronger underwriting results and investment gains. Below is a concise, data-driven snapshot based on the last four years of quarterly statements provided.

  • Net income growth and earnings power: Net income attributable to common shareholders rose to about $198.5M in Q4 2025, up from $167.9M in Q4 2024. Basic EPS was $5.58 and diluted EPS $5.46 in Q4 2025, versus $4.66 and $4.60 in Q4 2024.
  • Revenue expansion: Total revenue climbed to roughly $1.656B in Q4 2025 from about $1.589B in Q4 2024, signaling stronger topline performance.
  • Higher premiums earned: Premiums earned increased to about $1.5566B in Q4 2025 from $1.5116B in Q4 2024, supporting improved underwriting activity.
  • Investment gains contributing to income: Net realized and unrealized capital gains on investments rose to about $108.2M in Q4 2025 from $73.4M in Q4 2024, adding to non-operating income.
  • Liquidity & capitalization context: As of mid-2025, THG’s balance sheet shows a large asset base (Total Assets around $16.77B) with substantial equity (Total Common Equity about $3.43B), indicating solid capitalization and liquidity.
  • Invested asset base: Trading account securities sit at a high level (around $9.68B in the 2025 period), reflecting a heavy invested asset portfolio that supports earnings but adds market risk to consider.
  • Dividend policy stability: Quarterly dividend payments have been fairly steady in the low-$30Ms range, providing predictable capital returns to shareholders without material growth signals yet.
  • Non-interest expense pressure: Total Non-Interest Expense rose to about $1.4026B in Q4 2025 from about $1.3698B in Q4 2024, implying margin pressure from higher costs.
  • Leverage consideration: Long-Term Debt rose to roughly $843M by Q3 2025, signaling higher leverage that could influence risk and funding costs if not offset by earnings growth.
  • Financing activities providing less cash: Net cash from financing activities was negative in Q4 2025 (about -$149.6M), which reduced cash available from financing channels in the quarter.
05/08/26 05:34 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About The Hanover Insurance Group's Financials

When does The Hanover Insurance Group's fiscal year end?

According to the most recent income statement we have on file, The Hanover Insurance Group's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

How has The Hanover Insurance Group's net income changed over the last 10 years?

The Hanover Insurance Group's net income appears to be on an upward trend, with a most recent value of $662.50 million in 2025, rising from $331.50 million in 2015. The previous period was $426 million in 2024. Find out what analysts predict for The Hanover Insurance Group in the coming months.

How has The Hanover Insurance Group's revenue changed over the last 10 years?

Over the last 10 years, The Hanover Insurance Group's total revenue changed from $4.99 billion in 2015 to $6.54 billion in 2025, a change of 31.0%.

How much debt does The Hanover Insurance Group have?

The Hanover Insurance Group's total liabilities were at $13.37 billion at the end of 2025, a 7.6% increase from 2024, and a 22.3% increase since 2015.

How much cash does The Hanover Insurance Group have?

In the past 10 years, The Hanover Insurance Group's cash and equivalents has ranged from $120.60 million in 2020 to $1.12 billion in 2025, and is currently $1.12 billion as of their latest financial filing in 2025.


Related Companies

Financial statements for NYSE:THG last updated on 5/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Massive Data Leak Exposes 512,000-Line Code That Could Change Society Forever
"You won't believe what I discovered at 4 World Trade Center" When our financial media correspondent travel...
Chaikin Analytics | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
One executive order. The biggest wealth transfer of your lifetime.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Is the SpaceX IPO “Rigged?”
The SpaceX IPO filing is official, with 21 banks - including JPMorgan, Goldman Sachs, and Morgan Stanley - pre...
The Oxford Club | Sponsoredtc pixel
I’m sounding the alarm
Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...
Porter & Company | Sponsoredtc pixel
Iran War Update: Trump’s Hand-Written Letter Reveals What Comes Next
Jim Rickards has uncovered what he believes is Trump's economic plan, with a key trigger date of May 15. The F...
Paradigm Press | Sponsoredtc pixel